Search

Your search keyword '"Lin, Xiaoyan"' showing total 188 results

Search Constraints

Start Over You searched for: Author "Lin, Xiaoyan" Remove constraint Author: "Lin, Xiaoyan" Publisher elsevier bv Remove constraint Publisher: elsevier bv
188 results on '"Lin, Xiaoyan"'

Search Results

1. The suppression of FSP1 expression via NRF2 promotes ferroptosis induced by reactive oxygen species in vascular smooth muscle cells

3. Mussel-inspired superhydrophilic and antibacterial membranes for effective gravity-driven separation of oil-in-water emulsions

4. High-performance antibacterial tight ultrafiltration membrane constructed by co-deposition of dopamine and tobramycin for sustainable high-salinity textile wastewater management

9. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

12. Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

15. Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

19. Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial

22. A novel tree shrew model of lipopolysaccharide-induced acute respiratory distress syndrome

25. TEAD Proteins Associate With DNA Repair Proteins to Facilitate Cellular Recovery From DNA Damage

26. Bamboo pulp-based electret fiber aerogel with enhanced electret performance by P-phenylenediamine modification for simulated radioactive aerosol purification in confined spaces

29. KN026 (anti-HER2 bispecific antibody) in patients with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancer

39. Camrelizumab Plus Apatinib in Treatment-Naive Patients With Advanced Nonsquamous NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 2 Trial

Catalog

Books, media, physical & digital resources